Pregnanediol-3-glucuronide (abbreviated as PDG or PdG), formally known as 5β-pregnane-3α,20α-diol 3-glucuronide, is the principal end-stage metabolite of progesterone in humans. Clinically, its measurement is utilized to assess ovulation and evaluate luteal phase function.

AccuSift provides high-performance competitive antibody pairs for pregnanediol-3-glucuronide detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: ELISA LOD: 2 ng/mL